Nanopore-based metagenomic sequencing analysis of control subjects and patients with AD. (PRJCA020467)
To explore alterations in the gut microbiota of individuals with Alzheimer's disease (AD), we collected 26 fecal samples from AD patients, matched for gender and age, as well as 26 samples from healthy controls. DNA was extracted from these samples and subjected to Nanopore third-generation sequencing. Using metagenomics methods to analyze.